Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow-to-Debt Ratio
Shanghai Rendu Biotechnology Co. Ltd. A cash flow-to-debt ratio. Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow-to-Debt Ratio of 0.29x as of December 2025, meaning its operating cash flow of CN¥22.41 Million could theoretically repay 0% of its total liabilities (CN¥76.26 Million) in one year. Check 688193 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Cash flow-to-debt ratio of Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025. Historical debt coverage capacity for Shanghai Rendu Biotechnology Co. Ltd. A across 7 annual periods. Check Shanghai Rendu Biotechnology Co. Ltd. A (688193) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2019–2025)
Shanghai Rendu Biotechnology Co. Ltd. A cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Shanghai Rendu Biotechnology Co. Ltd. A. For the full cash flow conversion analysis, see 688193 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥22.41 Million | CN¥76.26 Million | ▼ -0.6% |
| 2024 | 0.30x | CN¥24.39 Million | CN¥82.48 Million | ▲ +58.2% |
| 2023 | 0.19x | CN¥17.19 Million | CN¥91.97 Million | ▲ +681.8% |
| 2022 | -0.03x | CN¥-4.09 Million | CN¥127.34 Million | ▼ -105.4% |
| 2021 | 0.60x | CN¥54.44 Million | CN¥90.86 Million | ▼ -38.0% |
| 2020 | 0.97x | CN¥92.61 Million | CN¥95.75 Million | ▲ +157.7% |
| 2019 | 0.38x | CN¥13.67 Million | CN¥36.41 Million | — |